- Home
- Publications
- Publication Search
- Publication Details
Title
Vancomycin dosing and monitoring 2 years after the guidelines
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 9, Issue 6, Pages 657-667
Publisher
Informa UK Limited
Online
2011-06-22
DOI
10.1586/eri.11.46
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
- (2011) Ian M. Gould et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Estimating the Glomerular Filtration Rate in Obese Adult Patients for Drug Dosing
- (2010) Manjunath P. Pai ADVANCES IN CHRONIC KIDNEY DISEASE
- Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus
- (2010) Y. Yang et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Vancomycin-Associated Nephrotoxicity: Grave Concern or Death by Character Assassination?
- (2010) Kathleen A. Hazlewood et al. AMERICAN JOURNAL OF MEDICINE
- Generic Vancomycin Products Fail In Vivo despite Being Pharmaceutical Equivalents of the Innovator
- (2010) O. Vesga et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation
- (2010) Natalia Revilla et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Optimizing initial vancomycin dosing in burn patients
- (2010) Marion Elligsen et al. BURNS
- Relationship of Vancomycin Minimum Inhibitory Concentration to Mortality in Patients With Methicillin-Resistant Staphylococcus aureus Hospital-Acquired, Ventilator-Associated, or Health-care-Associated Pneumonia
- (2010) Nadia Z. Haque et al. CHEST
- Guiding Clinical Care through Evidence‐Free Zones
- (2010) Stan Deresinski CLINICAL INFECTIOUS DISEASES
- Quality and Strength of Evidence of the Infectious Diseases Society of America Clinical Practice Guidelines
- (2010) Abdur Rahman Khan et al. CLINICAL INFECTIOUS DISEASES
- Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
- (2010) B. P. Howden et al. CLINICAL MICROBIOLOGY REVIEWS
- Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy
- (2010) Annie Wong-Beringer et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A higher dose of vancomycin in continuous infusion is needed in critically ill patients
- (2010) A. Jeurissen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Recent changes in vancomycin use in renal failure
- (2010) Stefaan J. Vandecasteele et al. KIDNEY INTERNATIONAL
- Use of Vancomycin in Pediatrics
- (2010) Walter Dehority PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Influence of Vancomycin on Renal Function in Critically Ill Patients after Cardiac Surgery
- (2009) Doris Hutschala et al. ANESTHESIOLOGY
- Is Vancomycin Ototoxicity a Significant Risk?
- (2009) R. K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospectively Validated Dosing Nomograms for Maximizing the Pharmacodynamics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients
- (2009) F. Pea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nine-Hospital Study Comparing Broth Microdilution and Etest Method Results for Vancomycin and Daptomycin against Methicillin-Resistant Staphylococcus aureus
- (2009) H. S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Vancomycin at Simulated Epithelial Lining Fluid Concentrations against Methicillin-Resistant Staphylococcus aureus (MRSA): Implications for Dosing in MRSA Pneumonia
- (2009) Y. Harigaya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Continuous Infusion of Vancomycin Less Effective and Safe than Intermittent Infusion, Based on Pharmacodynamic and Pharmacokinetic Principles
- (2009) Prachant Nannan Panday et al. CLINICAL INFECTIOUS DISEASES
- Reply to Panday and Sturkenboom
- (2009) Michael J. Rybak et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin in Combination with Other Antibiotics for the Treatment of Serious Methicillin‐ResistantStaphylococcus aureusInfections
- (2009) Stan Deresinski CLINICAL INFECTIOUS DISEASES
- Paradoxical Relationship between the Clinical Outcome ofStaphylococcus aureusBacteremia and the Minimum Inhibitory Concentration of Vancomycin
- (2009) James Price et al. CLINICAL INFECTIOUS DISEASES
- Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients
- (2009) Thomas P. Lodise et al. CLINICAL INFECTIOUS DISEASES
- Should the Currently Recommended Twice-Daily Dosing Still be Considered the Most Appropriate Regimen for Treating MRSA Ventilator-Associated Pneumonia with Vancomycin?
- (2009) Federico Pea et al. CLINICAL PHARMACOKINETICS
- Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics
- (2009) Kyra Chua et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Loss of vancomycin bactericidal activity against accessory gene regulator (agr) dysfunctional Staphylococcus aureus under conditions of high bacterial density
- (2009) Brian T. Tsuji et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy
- (2009) Paul R. Ingram et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides
- (2009) S. N. Leonard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia
- (2009) Carlos A. Rodriguez et al. JOURNAL OF INFECTION
- Reduced Susceptibility to Vancomycin Influences Pathogenicity inStaphylococcus aureusInfection
- (2009) Anton Y. Peleg et al. JOURNAL OF INFECTIOUS DISEASES
- Is High Vancomycin Minimum Inhibitory Concentration a Good Marker to Predict the Outcome of Methicillin‐ResistantStaphylococcus aureusBacteremia?
- (2009) Antonio Lalueza et al. JOURNAL OF INFECTIOUS DISEASES
- Human Organ/Tissue Growth Algorithms that Include Obese Individuals and Black/White Population Organ Weight Similarities from Autopsy Data
- (2009) John F. Young et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES
- Current Recommended Dosing of Vancomycin for Children With Invasive Methicillin-Resistant Staphylococcus aureus Infections Is Inadequate
- (2009) Adam Frymoyer et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
- (2008) M. Rybak et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Vancomycin MICs for Methicillin-Resistant Staphylococcus aureus Isolates Differ Based upon the Susceptibility Test Method Used
- (2008) V. Prakash et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin Ototoxicity: a Reevaluation in an Era of Increasing Doses
- (2008) A. Forouzesh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin
- (2008) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity
- (2008) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms
- (2008) Martin E. Stryjewski et al. CLINICAL INFECTIOUS DISEASES
- In vitro susceptibility of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) to manufactured generic drugs compared with the brand vancomycin
- (2008) Shigeru Fujimura et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy
- (2008) P. R. Ingram et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations
- (2008) S. N. Leonard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Gene Expression Analysis Reveals New Possible Mechanisms of Vancomycin-Induced Nephrotoxicity and Identifies Gene Markers Candidates
- (2008) Christine Dieterich et al. TOXICOLOGICAL SCIENCES
- Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2007) A. Soriano et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started